FDA License to Operate Renewal in the Philippines: Window, Documents and Lapse Consequences

First, disambiguate: the Philippines has two things called LTO

Search "LTO renewal Philippines" and you get two unrelated subjects: the Food and Drug Administration's License to Operate (LTO), and the Land Transportation Office (also LTO), which handles driver's licences and vehicle registration. This article is about the first.

The collision causes real confusion. Most search results for LTO renewal are about driving, simply because far more people renew licences than renew FDA permits. If that is what you need, see the driver's licence guide for foreigners and vehicle registration renewal — this article will not help.

If you need the FDA licence, you are most likely one of these: an importer or trader of food, cosmetics, food supplements, drugs or medical devices; a manufacturer of those categories in the Philippines; or a licensed local agent. The LTO is your legal standing to import and sell regulated products, and without it product registration has nothing to hang from. For the first-time process, see FDA product registration: LTO and CPR. This guide covers renewal, and what happens when a licence lapses.

When the LTO lapses, every product registration under it loses the holder it depends on — the cargo is at the port, but you are no longer a legally standing importer. Have Yixing check your LTO expiry and renewal window →

The renewal window: when you can file, and when you must

Renewal is not "any time before expiry." There is a defined window, and both edges bite.

Under Administrative Order No. 2024-0015, renewal applications are to be filed within the window of 90 calendar days before the licence expires. Two constraints follow:

• Not too early. The system generally will not accept a renewal filed well ahead of the window. Getting it out of the way early usually gets bounced.
• Not too late. File after the expiry date and it is no longer a renewal — the nature, cost and resulting validity all change, as the next sections explain.

The FDA has issued advisories granting interim extensions of this filing period. Interim arrangements change; verify the current FDA advisory before filing rather than planning against a date in any article.

In practice, pull every milestone earlier:

1. 150 days out: inventory the attachments. Which have expired, is the authorisation letter still valid, is the Qualified Person still employed.
2. 120 days out: start re-obtaining documents from third parties — the slowest leg, because you do not control it.
3. 90 days out: file the moment the window opens, preserving room for review and deficiencies.
4. 30 days out: if there is no acknowledgement or deficiency letter yet, chase it.

Why leave 60 days of slack? Because review can produce a deficiency letter with its own reply deadline. File on the window's last day, receive a deficiency notice, and the licence may expire before your response lands.

What AO 2024-0015 changed: validity now scales with company size

This is the most substantive change in years. Administrative Order No. 2024-0015 was issued on 27 November 2024, took effect on 12 January 2025, and repealed Administrative Order No. 2020-0017, resetting the rules, requirements and procedures for License to Operate applications by covered health product establishments.

The core change: validity is no longer a flat "2 years initial, 5 years on renewal." It is tiered by enterprise size, and renewal validity substantially exceeds initial validity. Broadly:

Treat this table as indicative and defer to current FDA issuances and to what your actual licence states — rollout pace differs by product category and implementing advisories continue to issue. Do not plan cash flow from the table; plan from the expiry date printed on your licence.

The change has 3 practical effects:

• Good news: far fewer filings. A medium-sized importer that used to renew roughly every 5 years can now hold a licence for 12 years on one renewal.
• Bad news: lapsing costs more than it used to. Precisely because renewal yields 6 or 12 years, being pushed back to initial-application treatment yields 3 or 6 — effectively forfeiting half the validity.
• The subtle one: longer cycles are easier to forget. Over 12 years the responsible staff will likely have turned over two or three times. The expiry date belongs in a compliance calendar, not in one person's memory. See building a Philippine compliance calendar.

The order also strengthened Qualified Person requirements and set out the grounds on which the FDA decides applications and acts on issued licences. If your Qualified Person has left or no longer meets the criteria, that single item will stall the whole renewal.

What renewal requires: 4 differences from a first application

Renewal is not the initial file submitted again. Four differences matter:

1. You are not proving who you are; you are proving nothing changed. An initial application establishes the entity. A renewal confirms that entity details, address, scope, ownership and responsible officers are unchanged. Anything that did change usually belongs in a variation application, not a renewal — two separate tracks. Do not expect to slip an address change into a renewal.

2. The Qualified Person's credentials must be current. Appointment letter, qualifications and proof of employment are focal points on review. A departed employee, an expired credential, or one person named across several establishments are all common blockers.

3. Premises and quality system evidence must be refreshed. Lease or title, floor plan, storage conditions (particularly cold chain), quality documentation — anything with a validity period must cover the new cycle. A lease shorter than the licence term you are applying for is a frequent query: apply for 12 years on a lease with 2 years left and the reviewer will ask.

4. Your compliance history is reviewed. Inspections, adverse event reports and recalls during the previous cycle come back into view.

A general preparation list (defer to the FDA's current category-specific checklist):

1. Valid SEC or DTI registration and articles, if amended.
2. Current Mayor's Permit — see business permit renewal.
3. BIR certificate of registration and TIN.
4. Qualified Person appointment, credentials and proof of employment.
5. Lease or title covering the licence period applied for.
6. Floor plan and storage or cold chain description.
7. Quality management and traceability documentation.
8. Foreign brand authorisation letter where applicable, noting its own validity.
9. Prescribed renewal and related fees.

Categories add their own items: cosmetics notification, food supplement registration, and medical device import licensing.

How eServices actually works: fully online, but attachments are the bottleneck

FDA licensing and registration has moved to the eServices portal (e-Portal 2.0). Per FDA advisories implementing AO 2024-0015, categories were onboarded in waves, with drug distributors, drug traders and pharmaceutical outlets piloting from 20 January 2025 and other establishment types to follow on separately announced dates. Different categories switched at different times, so confirm which entry point applies to yours before filing.

The online sequence:

1. Account: log in with the entity account bound to your establishment. The registered email is the address for official notices — make sure someone reads it, and update it when staff change.
2. Application type: Initial, Renewal or Variation. Choosing wrongly gets the whole filing returned.
3. Complete and upload: attachments per the category checklist. Format, size and naming conventions are enforced, and non-compliant files bounce at pre-assessment.
4. Pay: some categories require a pre-assessment fee before submission, with licensing fees after.
5. Review and deficiencies: respond within the deadline stated in any deficiency letter.
6. Issuance: approved licences are issued electronically.

What stalls filings is rarely the process — it is the attachments. Three problems recur: scans that are unclear or missing pages; documents past their validity (Mayor's Permit and authorisation letters especially); and the company name written inconsistently across attachments — even the difference between Inc. and Corp. gets flagged.

Run a consistency check before filing: copy the exact corporate name from the SEC certificate and verify every attachment matches it, name and address alike. Thirty minutes here saves a deficiency round.

When the licence lapses: not a late fee, a demotion

This is the section to read twice. Most companies assume an expired LTO means a modest fine. The consequences come in 3 layers, and they stack.

Layer 1: surcharge. Filing a renewal after expiry attracts a surcharge. Under the FDA's current computation rules, derived from the implementing rules of Republic Act No. 9711, the commonly applied formula is twice the renewal fee, plus 10% of the renewal fee for each month of delay. The exact computation and any cap follow current FDA issuances, but the direction is unambiguous: the longer you wait, the more it costs, and it compounds monthly.

Layer 2: the filing changes character — renewal becomes initial. Applications filed beyond the prescribed period are processed as initial applications. That costs far more than the surcharge:

• The full initial documentation set must be rebuilt.
• Review runs on the initial timeline, generally longer.
• The validity granted drops from the renewal tier to the initial tier — 12 years to 6 for a medium or large enterprise, 6 years to 3 for a micro or small one.

File late and the penalty is not a late fee but a demotion: processed as a new application, a medium-sized company's validity falls from 12 years to 6 — six years gone. Have Yixing map every FDA licence you hold onto one expiry schedule →

Layer 3: you cannot lawfully operate while lapsed. The most expensive layer. The LTO is your statutory standing to import, distribute and sell in that category, and while it is invalid those activities lose their legal basis. Concretely:

• Cargo stops at the port. Clearance of regulated goods involves verifying the importer's FDA standing. An invalid licence fails that check while demurrage and detention accrue — see what to do when customs holds your shipment.
• New product registrations and variations cannot be filed, since they presuppose a valid operating licence.
• Products already in the channel carry exposure. Being unable to produce a valid licence on inspection is a clear violation.

When the LTO goes, the product registrations go with it

The Philippine FDA framework runs in two stages: the establishment's License to Operate first, then the product's Certificate of Product Registration (CPR) or notification. The CPR hangs from the LTO; it does not stand alone.

Three consequences follow:

• No valid LTO, no valid foundation for the CPR. When the licence lapses, the registrations under it lose their holder and the products' lawful market standing is undermined.
• The LTO validity is effectively a ceiling on the CPR. Product registration does not extend beyond the coverage of the holder's licence, so the two must be managed together.
• Changing the licence holder is a major project. If a lapse forces you to move to a different licensed entity, every product registration must migrate or be refiled. The more SKUs, the worse it gets — for an importer with 40 SKUs, refiling costs far more time and money than the renewal ever would have.

One more detail worth knowing: under the prepackaged food labelling rules, the Food Authorization Number (FAN) may be printed on the label, and the FAN consists of the LTO number and the product registration (FR) number. In other words, your operating licence number is printed on the packaging. Changing holder means changing LTO number, which can mean reprinting artwork already produced. Full labelling rules are in the prepackaged food labelling requirements guide.

The right mental model: the LTO is not a certificate to renew on time — it is the foundation your entire portfolio sits on. Manage its expiry alongside your product registration expiries.

Six common deficiency reasons, and a backward schedule

Ranked by how often they occur:

1. An expired Mayor's Permit. It renews annually and does not align with the FDA cycle, so a lapse often surfaces only at renewal.
2. The Qualified Person has left or credentials expired. With cycles now running 6 or 12 years, the odds of this rise sharply.
3. A lease shorter than the licence term applied for. Twelve years requested against 2 years of lease invites a query.
4. Company name or address written inconsistently across attachments — suffixes, punctuation, floor notation included.
5. An expired brand authorisation letter, or one whose scope does not match the categories applied for.
6. Entity details actually changed but filed as a renewal. A move, an ownership change or a scope adjustment belongs in a variation first.

Backward schedule (D = licence expiry date):

Pin that table above the responsible person's desk — it beats memorising any single figure. The real risk in renewal is not procedural complexity but a cycle so long that nobody remembers.

From expiry inventory and document pre-review through eServices filing, deficiency responses and remediation planning after a lapse, Yixing's product access team can take it on. If you hold several FDA licences, or one has already expired, send us the numbers and expiry dates and we will risk-rank them first.

See also: the full FDA product registration guide, restricted and regulated imports, the customs clearance process.

Disclaimer: This article is a general overview and not legal advice. Validity tiers, filing window days, surcharge computation and rollout timing are governed by the FDA's current administrative orders and advisories and by what your issued licence states; these rules have changed repeatedly in recent years, so verify current issuances before filing. Obtain professional advice for your specific case.